HSIC
62
-3
SPG
53
2
GT
39
2
SLG
37
6
ROST
70
2
KIM
56
5
NKE
36
6
EXPD
48
-2
PEG
50
4
AAPL
55
2
EL
59
-2
CPB
37
2
MO
57
4
ADT
48
2
MDLZ
28
4
LH
48
2
EXR
26
2
SWKS
56
8
SO
53
5
ADM
47
2
HSIC
62
-3
SPG
53
2
GT
39
2
SLG
37
6
ROST
70
2
KIM
56
5
NKE
36
6
EXPD
48
-2
PEG
50
4
AAPL
55
2
EL
59
-2
CPB
37
2
MO
57
4
ADT
48
2
MDLZ
28
4
LH
48
2
EXR
26
2
SWKS
56
8
SO
53
5
ADM
47
2
Financhill
Back

Infinity Pharmaceuticals, Inc. 10K Form

Sell
41

INFIQ
Infinity Pharmaceuticals, Inc.

Last Price:
$0.0000
Seasonality Move:
1.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INFIQ News And Ratings

See the #1 stock for the next 7 days that we like better than INFIQ

INFIQ Financial Statistics

Sales & Book Value

Annual Sales: $2.6M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0

Profitability

Net Income (TTM): $0
Gross Margin: $572K
Return on Equity: 0%
Return on Assets: 0%

Infinity Pharmaceuticals, Inc. Earnings Forecast

Key Infinity Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 24 years for INFIQ is 22.06%.
  • The Selling, General & Administrative Expenses for INFIQ have been equal to 519.21% of Gross Profit Margin.
  • The Research & Development expenses have been 1,232.28% of Revenue.
  • The Net Earning history of INFIQ is -1,711.11% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 14 years.

Infinity Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: INFIQ
Website: infi.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INFIQ Technical Analysis vs Fundamental Analysis

Sell
41
Infinity Pharmaceuticals, Inc. (INFIQ) is a Sell

Is Infinity Pharmaceuticals, Inc. a Buy or a Sell?